Acasă › Cancer pulmonar cu celule non-pătrate › Iowa › Cedar Rapids
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Cedar Rapids, IA
20 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Cedar Rapids (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
În curs de recrutareFaza 3
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
În curs de recrutareFaza 3
- University of Iowa Hospitals & Clinics, Iowa City · La 25 mi distanță
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Local Institution - 0065, Iowa City · La 25 mi distanță
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
În curs de recrutareFaza 3
- Mercy Medical Center, Cedar Rapids
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
În curs de recrutareFaza 2/3
- Physicians Clinic of Iowa, Cedar Rapids
- Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City · La 25 mi distanță
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
În curs de recrutareFaza 1
- University of Iowa Hospital and Clinics, Iowa City · La 25 mi distanță
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
În curs de recrutareFaza 1
- University of Iowa, Iowa City · La 25 mi distanță
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- University of Iowa, Iowa City · La 25 mi distanță
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
În curs de recrutareFaza 1/2
- University of Iowa Hospitals & Clinics PARENT, Iowa City · La 25 mi distanță
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- University of Iowa, Iowa City · La 25 mi distanță
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
În curs de recrutareFaza 1
- University of Iowa, Iowa City · La 25 mi distanță
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
În curs de recrutareFaza 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
În curs de recrutareFaza 1
- University of Iowa Health Care, Iowa City · La 25 mi distanță
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
În curs de recrutareFaza 1
- University of Iowa Hospitals & Clinics, Iowa City · La 25 mi distanță
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
În curs de recrutareFaza 2
- University of Iowa Hospitals and Clinics, Iowa City · La 25 mi distanță
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · La 25 mi distanță
GEMINI-NSCLC: NSCLC Biomarker Study
În curs de recrutareStudiu observațional
- University of Iowa, Iowa City · La 25 mi distanță
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Iowa City · La 25 mi distanță
Test-retest Evaluation of [18F]F-AraG PET
În curs de recrutareFaza 2
- University of Iowa Hospitals and Clinics, Iowa City · La 25 mi distanță
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Cedar Rapids
- Cancer de sân17 studii
- Cancer (toate tipurile)16 studii
- Leucemie mieloasă acută16 studii
- Mielom multiplu15 studii
- Cancer pulmonar14 studii
- Cancer colorectal13 studii
- Carcinom cu celule scuamoase de cap și gât12 studii
- Cancer de prostată12 studii
- Accident vascular cerebral10 studii
- Melanom10 studii
- Cancer endometrial9 studii
- Cancer hematologic9 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.